SEC Filing

SEC Filing Details

Document Details

Filing Date
Mar 18, 2022
Document Date
Mar 18, 2022
Form Description
Post-effective amendment to an S-Type filing
Filing Group
Registration Statements
Company
Reviva Pharmaceuticals
Issuer
REVIVA PHARMACEUTICALS HOLDINGS, INC.